Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2962705 | 0.77 | CYP3A4 (0.54) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL12562679 | 0.73 | CYP3A4 (0.58) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL17878603 | 0.72 | CYP3A4 (0.44) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11782680 | 0.69 | CYP3A4 (0.48) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL17860890 | 0.69 | CYP3A4 (0.48) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL8980152 | 0.69 | LPAR3 (0.51) | LPAR3LPAR2LPAR1FDPSSMPD1 | |
| SCHEMBL17878604 | 0.68 | CYP3A4 (0.42) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11050434 | 0.67 | CYP3A4 (0.56) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL8837154 | 0.67 | CYP3A4 (0.56) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| Isopropyl Alcohol SCHEMBL28141271 | 0.67 | CYP3A4 (0.77) | CYP3A4LPAR3LPAR2LPAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1808437-B1 | METHOD FOR PRODUCING PHOSPHORUS COMPOUNDS HAVING PHOSPHATE-PHOSPHONATE BOND | DAIHACHI CHEM IND (JP) | 2013-09-11 | — | — | EP | disclosed |
| EP-1810975-B1 | METHOD FOR PRODUCING PHOSPHONATES HAVING AN ALCOHOLIC HYDROXY GROUP | DAIHACHI CHEM IND (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-7772440-B2 | Process for preparing phosponates having alcoholic hydroxyl group | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-08-10 | — | — | US | disclosed |
| US-7728162-B2 | Process for preparing phosphorus compounds having phosphate-phosphonate bond | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090062554-A1 | dehydrohalogenation, oxidation; by-product inhibition; catalyst-free | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090062568-A1 | PROCESS FOR PREPARING PHOSPHONATES HAVING ALCOHOLIC HYDROXYL GROUP | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1810975-A1 | METHOD FOR PRODUCING PHOSPHONATE HAVING ALCOHOLIC HYDROXY GROUP | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-25 | — | — | EP | disclosed |
| EP-1808437-A1 | METHOD FOR PRODUCING PHOSPHORUS COMPOUND HAVING PHOSPHATE-PHOSPHONATE BOND | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062568-A1 | PROCESS FOR PREPARING PHOSPHONATES HAVING ALCOHOLIC HYDROXYL GROUP | PHOSPHO1, ADH1C, ADH1A | CYP3A4 1057/4885LPAR3 2071/4885LPAR2 2227/4885 |
| US-20090062554-A1 | dehydrohalogenation, oxidation; by-product inhibition; catalyst-free | GNPAT, POR, ADH1A | CYP3A4 89/4885LPAR3 4853/4885LPAR2 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.